Charlie Abela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Charlie Abela has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Jeremy Debattista
University of Malta
3 shared publications - Lilian M. Azzopardi
Department of Pharmacy University of Malta Msida Malta
3 shared publications - Lizzy Farrugia
University of Malta
3 shared publications Jeremy Debattista
Department of Artificial Intelligence, University of Malta, Msida, Malta
2 shared publicationsLilian M. Azzopardi
Department of Pharmacy, University of Malta, Msida, Malta
2 shared publicationsLizzy Farrugia
Department of Artificial Intelligence, University of Malta, Msida, Malta
2 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Springer Nature in Journal of Biomedical Semantics
- Vol. 16 (1) , 1-27
medicX-KG: a knowledge graph for pharmacists’ drug information needs
The role of pharmacists is evolving from medicine dispensing to delivering comprehensive pharmaceutical services within multidisciplinary healthcare teams. Central to this shift is access to accurate, up-to-date medicinal product information supported by robust data integration. Leveraging artificial intelligence and semantic technologies, Knowledge Graphs (KGs) uncover hidden relationships and enable data-driven decision-making. This paper presents medicX-KG, a pharmacist-oriented knowledge graph supporting clinical and regulatory decisions. It forms the semantic layer of the broader medicX platform, powering predictive and explainable pharmacy services. medicX-KG integrates data from three sources, including, the British National Formulary (BNF), DrugBank, and the Malta Medicines Authority (MMA) that addresses Malta’s regulatory landscape and combines European Medicines Agency alignment with partial UK supply dependence. The KG tackles the absence of a unified national drug repository, reducing pharmacists’ reliance on fragmented sources. Its design was informed by interviews with practising pharmacists to ensure real-world applicability. We detail the KG’s construction, including data extraction, ontology design, and semantic mapping. Evaluation demonstrates that medicX-KG effectively supports queries about drug availability, interactions, adverse reactions, and therapeutic classes. Limitations, including missing detailed dosage encoding and real-time updates, are discussed alongside directions for future enhancements.
- 1 July 2025
- Published by Springer Nature in Journal of Biomedical Semantics
- Vol. 16 (1) , 1-27
Open AccessmedicX-KG: a knowledge graph for pharmacists’ drug information needs
The role of pharmacists is evolving from medicine dispensing to delivering comprehensive pharmaceutical services within multidisciplinary healthcare teams. Central to this shift is access to accurate, up-to-date medicinal product information supported by robust data integration. Leveraging artificial intelligence and semantic technologies, Knowledge Graphs (KGs) uncover hidden relationships and enable data-driven decision-making. This paper presents medicX-KG, a pharmacist-oriented knowledge graph supporting clinical and regulatory decisions. It forms the semantic layer of the broader medicX platform, powering predictive and explainable pharmacy services. medicX-KG integrates data from three sources, including, the British National Formulary (BNF), DrugBank, and the Malta Medicines Authority (MMA) that addresses Malta’s regulatory landscape and combines European Medicines Agency alignment with partial UK supply dependence. The KG tackles the absence of a unified national drug repository, reducing pharmacists’ reliance on fragmented sources. Its design was informed by interviews with practising pharmacists to ensure real-world applicability. We detail the KG’s construction, including data extraction, ontology design, and semantic mapping. Evaluation demonstrates that medicX-KG effectively supports queries about drug availability, interactions, adverse reactions, and therapeutic classes. Limitations, including missing detailed dosage encoding and real-time updates, are discussed alongside directions for future enhancements.
- Open Access
medicX-KG: A Knowledge Graph for Pharmacists' Drug Information Needs
The role of pharmacists is evolving from medicine dispensing to delivering comprehensive pharmaceutical services within multidisciplinary healthcare teams. Central to this shift is access to accurate, up-to-date medicinal product information supported by robust data integration. Leveraging artificial intelligence and semantic technologies, Knowledge Graphs (KGs) uncover hidden relationships and enable data-driven decision-making. This paper presents medicX-KG, a pharmacist-oriented knowledge graph supporting clinical and regulatory decisions. It forms the semantic layer of the broader medicX platform, powering predictive and explainable pharmacy services. medicX-KG integrates data from three sources, including, the British National Formulary (BNF), DrugBank, and the Malta Medicines Authority (MMA) that addresses Malta's regulatory landscape and combines European Medicines Agency alignment with partial UK supply dependence. The KG tackles the absence of a unified national drug repository, reducing pharmacists' reliance on fragmented sources. Its design was informed by interviews with practicing pharmacists to ensure real-world applicability. We detail the KG's construction, including data extraction, ontology design, and semantic mapping. Evaluation demonstrates that medicX-KG effectively supports queries about drug availability, interactions, adverse reactions, and therapeutic classes. Limitations, including missing detailed dosage encoding and real-time updates, are discussed alongside directions for future enhancements.
Open AccessmedicX-KG: A Knowledge Graph for Pharmacists' Drug Information Needs
The role of pharmacists is evolving from medicine dispensing to delivering comprehensive pharmaceutical services within multidisciplinary healthcare teams. Central to this shift is access to accurate, up-to-date medicinal product information supported by robust data integration. Leveraging artificial intelligence and semantic technologies, Knowledge Graphs (KGs) uncover hidden relationships and enable data-driven decision-making. This paper presents medicX-KG, a pharmacist-oriented knowledge graph supporting clinical and regulatory decisions. It forms the semantic layer of the broader medicX platform, powering predictive and explainable pharmacy services. medicX-KG integrates data from three sources, including, the British National Formulary (BNF), DrugBank, and the Malta Medicines Authority (MMA) that addresses Malta's regulatory landscape and combines European Medicines Agency alignment with partial UK supply dependence. The KG tackles the absence of a unified national drug repository, reducing pharmacists' reliance on fragmented sources. Its design was informed by interviews with practicing pharmacists to ensure real-world applicability. We detail the KG's construction, including data extraction, ontology design, and semantic mapping. Evaluation demonstrates that medicX-KG effectively supports queries about drug availability, interactions, adverse reactions, and therapeutic classes. Limitations, including missing detailed dosage encoding and real-time updates, are discussed alongside directions for future enhancements.
- Open Access
- 30 October 2024
- Published by Springer Nature in Research Square
medicX-KE: A Knowledge Graph for Pharmacists’ Drug Information Needs
The contribution of pharmacists to patient care is evolving from the traditional role of dispensing medicine to that of providing pharmaceutical services within a multidisciplinary healthcare context. An important component for this transformation towards a holistic patient-centric approach is the availability of relevant and up-to-date information about medicinal products that leverages a robust data collection mechanism. Over the past decade, Knowledge Graphs (KGs) have rev-olutionised the organisation and utilisation of vast biomedical data. Powered by Artificial Intelligence (AI) and advanced inferencing techniques, KGs unlock the potential to derive valuable insights, discover hidden relationships, and enable data-driven decision making. In this paper, we present the medicX-KE knowledge graph that is tailored to the Maltese pharmaceutical landscape. The KG serves as a centralised repository, integrating data from several authoritative sources, including DrugBank and the British National Formulary (BNF). We present a specific use case for our KG that relies on information related to medicine provided by the Malta Medicines Authority (MMA). In addition, we conducted interviews with six pharmacists to understand their needs and to obtain feedback on the suitability of the KG. We describe data acquisition, mappings, ontology design, construction, and evaluation of medicX-KE, and discuss the challenges faced and potential future enhancements.
- 30 October 2024
- Published by Springer Nature in Research Square
Open AccessmedicX-KE: A Knowledge Graph for Pharmacists’ Drug Information Needs
The contribution of pharmacists to patient care is evolving from the traditional role of dispensing medicine to that of providing pharmaceutical services within a multidisciplinary healthcare context. An important component for this transformation towards a holistic patient-centric approach is the availability of relevant and up-to-date information about medicinal products that leverages a robust data collection mechanism. Over the past decade, Knowledge Graphs (KGs) have rev-olutionised the organisation and utilisation of vast biomedical data. Powered by Artificial Intelligence (AI) and advanced inferencing techniques, KGs unlock the potential to derive valuable insights, discover hidden relationships, and enable data-driven decision making. In this paper, we present the medicX-KE knowledge graph that is tailored to the Maltese pharmaceutical landscape. The KG serves as a centralised repository, integrating data from several authoritative sources, including DrugBank and the British National Formulary (BNF). We present a specific use case for our KG that relies on information related to medicine provided by the Malta Medicines Authority (MMA). In addition, we conducted interviews with six pharmacists to understand their needs and to obtain feedback on the suitability of the KG. We describe data acquisition, mappings, ontology design, construction, and evaluation of medicX-KE, and discuss the challenges faced and potential future enhancements.
- Open Access
Graph Based Traffic Analysis and Delay Prediction
This research is focused on traffic congestion in the small island of Malta which is the most densely populated country in the EU with about 1,672 inhabitants per square kilometre (4,331 inhabitants/sq mi). Furthermore, Malta has a rapid vehicle growth. Based on our research, the number of vehicles increased by around 11,000 in a little more than 6 months, which shows how important it is to have an accurate and comprehensive means of collecting data to tackle the issue of fluctuating traffic in Malta. In this paper, we first present the newly built comprehensive traffic dataset, called MalTra. This dataset includes realistic trips made by members of the public across the island over a period of 200 days. We then describe the methodology we adopted to generate syntactic data to complete our data set as much as possible. In our research, we consider both MalTra and the Q-Traffic dataset, which has been used in several other research studies. The statistical ARIMA model and two graph neural networks, the spatial temporal graph convolutional network (STGCN) and the diffusion convolutional recurrent network (DCRNN) were used to analyse and compare the results with existing research. From the evaluation, we found that the DCRNN model outperforms the STGCN with the former resulting in MAE of 3.98 (6.65 in the case of the latter) and a RMSE of 7.78 (against 12.73 of the latter).
Open AccessGraph Based Traffic Analysis and Delay Prediction
This research is focused on traffic congestion in the small island of Malta which is the most densely populated country in the EU with about 1,672 inhabitants per square kilometre (4,331 inhabitants/sq mi). Furthermore, Malta has a rapid vehicle growth. Based on our research, the number of vehicles increased by around 11,000 in a little more than 6 months, which shows how important it is to have an accurate and comprehensive means of collecting data to tackle the issue of fluctuating traffic in Malta. In this paper, we first present the newly built comprehensive traffic dataset, called MalTra. This dataset includes realistic trips made by members of the public across the island over a period of 200 days. We then describe the methodology we adopted to generate syntactic data to complete our data set as much as possible. In our research, we consider both MalTra and the Q-Traffic dataset, which has been used in several other research studies. The statistical ARIMA model and two graph neural networks, the spatial temporal graph convolutional network (STGCN) and the diffusion convolutional recurrent network (DCRNN) were used to analyse and compare the results with existing research. From the evaluation, we found that the DCRNN model outperforms the STGCN with the former resulting in MAE of 3.98 (6.65 in the case of the latter) and a RMSE of 7.78 (against 12.73 of the latter).
- Open Access
- 11 June 2024
- Published by Springer Nature in Research Square
Predicting Drug-Drug Interactions Using Knowledge Graphs
In the last decades, people have been consuming and combining more drugsthan before, increasing the number of Drug-Drug Interactions (DDIs). To pre-dict unknown DDIs, recently, studies started incorporating Knowledge Graphs(KGs) since they are able to capture the relationships among entities provid-ing better drug representations than using a single drug property. In this paper,we propose an end-to-end framework that integrates several drug features frompublic drug repositories into a KG and embeds the nodes in the graph using var-ious translation, factorisation and Neural Network (NN) based KG Embedding(KGE) methods. Ultimately, we use a Machine Learning (ML) algorithm thatpredicts unknown DDIs. Among the different translation and factorisation-basedKGE models, we found that the best performing combination was the ComplExembedding method with a Long Short-Term Memory (LSTM) network, whichobtained an F 1-score of 95.19% on a dataset based on the DDIs found in Drug-Bank version 5.1.8. This score is 5.61% better than the state-of-the-art modelDeepDDI. Additionally, we also developed a graph auto-encoder model that usesa Graph Neural Network (GNN), which achieved an F 1-score of 91.94%. Con-sequently, GNNs have demonstrated a stronger ability to mine the underlyingsemantics of the KG than the ComplEx model, and thus using higher dimensionembeddings within the GNN can lead to state-of-the-art performance.
- 11 June 2024
- Published by Springer Nature in Research Square
Open AccessPredicting Drug-Drug Interactions Using Knowledge Graphs
In the last decades, people have been consuming and combining more drugsthan before, increasing the number of Drug-Drug Interactions (DDIs). To pre-dict unknown DDIs, recently, studies started incorporating Knowledge Graphs(KGs) since they are able to capture the relationships among entities provid-ing better drug representations than using a single drug property. In this paper,we propose an end-to-end framework that integrates several drug features frompublic drug repositories into a KG and embeds the nodes in the graph using var-ious translation, factorisation and Neural Network (NN) based KG Embedding(KGE) methods. Ultimately, we use a Machine Learning (ML) algorithm thatpredicts unknown DDIs. Among the different translation and factorisation-basedKGE models, we found that the best performing combination was the ComplExembedding method with a Long Short-Term Memory (LSTM) network, whichobtained an F 1-score of 95.19% on a dataset based on the DDIs found in Drug-Bank version 5.1.8. This score is 5.61% better than the state-of-the-art modelDeepDDI. Additionally, we also developed a graph auto-encoder model that usesa Graph Neural Network (GNN), which achieved an F 1-score of 91.94%. Con-sequently, GNNs have demonstrated a stronger ability to mine the underlyingsemantics of the KG than the ComplEx model, and thus using higher dimensionembeddings within the GNN can lead to state-of-the-art performance.
- Open Access
Predicting Drug-Drug Interactions Using Knowledge Graphs
In the last decades, people have been consuming and combining more drugs than before, increasing the number of Drug-Drug Interactions (DDIs). To predict unknown DDIs, recently, studies started incorporating Knowledge Graphs (KGs) since they are able to capture the relationships among entities providing better drug representations than using a single drug property. In this paper, we propose the medicX end-to-end framework that integrates several drug features from public drug repositories into a KG and embeds the nodes in the graph using various translation, factorisation and Neural Network (NN) based KG Embedding (KGE) methods. Ultimately, we use a Machine Learning (ML) algorithm that predicts unknown DDIs. Among the different translation and factorisation-based KGE models, we found that the best performing combination was the ComplEx embedding method with a Long Short-Term Memory (LSTM) network, which obtained an F1-score of 95.19% on a dataset based on the DDIs found in DrugBank version 5.1.8. This score is 5.61% better than the state-of-the-art model DeepDDI. Additionally, we also developed a graph auto-encoder model that uses a Graph Neural Network (GNN), which achieved an F1-score of 91.94%. Consequently, GNNs have demonstrated a stronger ability to mine the underlying semantics of the KG than the ComplEx model, and thus using higher dimension embeddings within the GNN can lead to state-of-the-art performance.
Open AccessPredicting Drug-Drug Interactions Using Knowledge Graphs
In the last decades, people have been consuming and combining more drugs than before, increasing the number of Drug-Drug Interactions (DDIs). To predict unknown DDIs, recently, studies started incorporating Knowledge Graphs (KGs) since they are able to capture the relationships among entities providing better drug representations than using a single drug property. In this paper, we propose the medicX end-to-end framework that integrates several drug features from public drug repositories into a KG and embeds the nodes in the graph using various translation, factorisation and Neural Network (NN) based KG Embedding (KGE) methods. Ultimately, we use a Machine Learning (ML) algorithm that predicts unknown DDIs. Among the different translation and factorisation-based KGE models, we found that the best performing combination was the ComplEx embedding method with a Long Short-Term Memory (LSTM) network, which obtained an F1-score of 95.19% on a dataset based on the DDIs found in DrugBank version 5.1.8. This score is 5.61% better than the state-of-the-art model DeepDDI. Additionally, we also developed a graph auto-encoder model that uses a Graph Neural Network (GNN), which achieved an F1-score of 91.94%. Consequently, GNNs have demonstrated a stronger ability to mine the underlying semantics of the KG than the ComplEx model, and thus using higher dimension embeddings within the GNN can lead to state-of-the-art performance.
- 11 October 2019
- Published by Springer Nature
- p. 626-645
NotaryPedia: A Knowledge Graph of Historical Notarial Manuscripts
- 11 October 2019
- Published by Springer Nature
- p. 626-645
NotaryPedia: A Knowledge Graph of Historical Notarial Manuscripts
- 8 February 2018
- Published by Springer Nature
- p. 32-43
Analysing and Visualising Parliamentary Questions: A Linked Data Approach
- 8 February 2018
- Published by Springer Nature
- p. 32-43
Analysing and Visualising Parliamentary Questions: A Linked Data Approach